Retatrutide and Survodutide Interaction

Monitor
Mechanism-based 55% confidence

Retatrutide and Survodutide have an interaction requiring monitoring for interaction with 55% confidence. Both Retatrutide and Survodutide affect insulin sensitivity or blood glucose. Monitor fasting glucose and HbA1c. Consider adding an insulin sensitizer (metformin/berberine). Both compounds affect the gi tract and pancreas, so monitoring these systems is recommended.

Compound Profiles

Retatrutide

Triple GLP-1/GIP/Glucagon Agonist | Weight Loss & Diabetes

Activates GLP-1 for appetite suppression, GIP for insulin sensitivity, and glucagon for increased energy expenditure and hepatic fat oxidation..

Half-life: ~6 days Typical dose: 0.5mg starting, titrate up to 8-12mg weekly weight loss, metabolic
insulin disrupting
View full profile

Survodutide

Dual GLP-1/Glucagon Receptor Agonist | Weight Loss & Diabetes

Dual agonism: GLP-1R reduces appetite and slows gastric emptying; GCGR increases energy expenditure and hepatic fat oxidation. EC50 0.

Half-life: Approximately 6 days (109-115 hours) Typical dose: 0.6mg starting, titrate up to 3.6-6.0mg weekly weight loss, metabolic
glp1 receptor cardiotoxicinsulin disrupting
View full profile

Combined Organ Load

GI Tract
low
Pancreas
low

Shared Safety Flags

2x 2 compounds affect insulin sensitivity (Retatrutide, Survodutide). Monitor fasting glucose and HbA1c.

Frequently Asked Questions

Can I take Retatrutide with Survodutide?

Yes, but with caution. Both Retatrutide and Survodutide affect insulin sensitivity or blood glucose. Monitor fasting glucose and HbA1c. Consider adding an insulin sensitizer (metformin/berberine). Regular monitoring is advised.

Is Retatrutide and Survodutide safe together?

Based on pharmacological analysis, this combination is considered monitor. However, shared safety flags include: insulin disrupting. Monitor accordingly.

What are the interactions between Retatrutide and Survodutide?

Both Retatrutide and Survodutide affect insulin sensitivity or blood glucose. Monitor fasting glucose and HbA1c. Consider adding an insulin sensitizer (metformin/berberine). This assessment has 55% confidence and is inferred from pharmacological mechanism analysis.

How should I time Retatrutide and Survodutide?

Retatrutide has a half-life of ~6 days and Survodutide has a half-life of Approximately 6 days (109-115 hours). No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: Retatrutide vs Survodutide

This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.